Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

BBC ETF Forecast & Price Targets

Compare
See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

BBC Analyst Ratings

Strong Buy
129ConsensusRatings
124Buy5Hold0Sell
Based on the Wall Street analyst consensus for 129 of BBC’s holdings.

BBC 12 Month Forecast

$108.42▲(157.34% Upside)
Based on Wall Street analyst 12-month price targets for 129 of Virtus LifeSci Biotech Clinical Trials ETF’s holdings in the last 3 months. The average price target is $108.42 with a high forecast of $150.31 and a low forecast of $71.19. The average price target represents a 157.34% change from the last price of $42.13.
Highest Price Target$150.31Average Price Target$108.42Lowest Price Target$71.19

BBC Stocks With Highest Upside Potential

BBC highest upside
NamePrice & ChangeAnalyst ConsensusAnalyst Price Target
Strong Buy$10.00(1539.34% Upside)
Strong Buy$14.67(864.91% Upside)
Strong Buy$19.00(775.58% Upside)
Strong Buy$10.25(720.00% Upside)
Strong Buy$6.13(664.67% Upside)

BBC Stocks With Highest Downside Potential

BBC highest downside
NamePrice & ChangeAnalyst ConsensusAnalyst Price Target
Strong Buy$169.00(22.03% Upside)
Strong Buy$32.00(23.84% Upside)
Strong Buy$141.50(27.65% Upside)
Strong Buy$51.11(27.81% Upside)
Strong Buy$52.88(29.34% Upside)

BBC ETF FAQ

What is BBC’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 129 of BBC’s holdings, Virtus LifeSci Biotech Clinical Trials ETF’s 12-month average price target is $108.42.
What is BBC’s upside potential, based on the analysts’ average price target?
BBC’s average price target of $108.42 represents a 157.34% upside from its last price of $42.13.
Is BBC a Buy, Sell or Hold?
Virtus LifeSci Biotech Clinical Trials ETF has a consensus rating of Strong Buy, based on the analyst consensus for 129 of BBC’s holdings: 124 rated Buy, 5 rated Hold and 0 rated Sell.
What is Virtus LifeSci Biotech Clinical Trials ETF’s price target?
The average price target for Virtus LifeSci Biotech Clinical Trials ETF is $108.42, based on Wall Street analyst 12-month price targets for 129 of BBC’s holdings, issued in the past 3 months. The highest price target is $150.31 and the lowest is $71.19. The average price target represents a 157.34% increase from the last price of $42.13.
What is BBC’s expense ratio?
BBC’s expense ratio is 0.65%.
How many holdings does BBC have?
BBC holds 130 assets.
How can I buy shares of BBC?
You can buy shares of BBC through a brokerage account. Compare brokers on our Best Online Brokers page.